Skip to main content
VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
3.330
-0.240 (-6.72%)
At close: Jul 2, 2024, 4:00 PM
3.320
-0.010 (-0.30%)
After-hours: Jul 2, 2024, 6:11 PM EDT

VistaGen Therapeutics Revenue

In the fiscal year ending March 31, 2024, VistaGen Therapeutics had annual revenue of $1.06M, a decrease of -568.72%. Revenue in the quarter ending March 31, 2024 was $197.30K with 12.17% year-over-year growth.

Revenue (ttm)
$1.06M
Revenue Growth
-568.72%
P/S Ratio
84.58
Revenue / Employee
$27,282
Employees
39
Market Cap
89.99M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.06M1.29M-568.72%
Mar 31, 2023-227.00K-1.34M-120.47%
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 20200--
Mar 31, 20190--
Mar 31, 20180--
Mar 31, 20171.25M--
Mar 31, 20160--
Mar 31, 20150--
Mar 31, 20140--
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.05B
American Well 254.57M
Werewolf Therapeutics 16.22M
Asensus Surgical 8.72M
EUDA Health Holdings 3.71M
Revenue Rankings

VTGN News

More News